News

Anthony Cannella has always been willing to try the newest treatments for lymphoma. So he readily agreed to sign up for a CAR-T clinical trial at Hollings.

Children who do not meet inclusion criteria for current peds studies now have a chance through an innovative program.

MUSC study shows that long-acting antiretroviral therapy for persons living with HIV can be administered safely and effectively at home.

The Moodivate app improved depression symptoms significantly more than usual care treatment in a clinical trial at 22 MUSC Health primary care practices.

Dr. Jennifer Dahne's focus on making behavioral health interventions accessible to more people has been recognized with a governor's award.

Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.

The cochlear implant team at MUSC Health adds a new clinical trial that’s testing a device that may reduce hearing loss that can happen as an implant goes in.

MUSC Hollings Cancer Center researchers will test whether e-cigarettes are a viable quit smoking option for people who decline other options.

“There's an incredible amount of excitement about this device.” MUSC prepares to place totally under-the-skin cochlear implants in patients with hearing loss.

The U.S. surgeon general is calling attention to the link between alcohol and cancer, a connection that may be news to the general public.